Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment

In randomized clinical trials (RCTs), the accurate estimation of marginal treatment effects is crucial for determining the efficacy of interventions. Enhancing the statistical power of these analyses is a key objective for statisticians. The increasing availability of historical data from registries, prior trials, and health records presents an opportunity to improve trial efficiency. However, many methods for historical borrowing compromise strict type I error rate control. Building on the work by Schuler et al. on prognostic score adjustment for linear models, this paper extends the methodology to the plug-in analysis proposed by Rosenblum and van der Laan using generalized linear models (GLMs) to further enhance the efficiency of RCT analyses without introducing bias. Specifically, we train a prognostic model on historical control data and incorporate the resulting prognostic scores as covariates in the plug-in GLM analysis of the trial data. This approach leverages the predictive power of historical data to improve the precision of marginal treatment effect estimates. We demonstrate that this method achieves local semi-parametric efficiency under the assumption of an additive treatment effect on the link scale. We expand the GLM plug-in method to include Negative Binomial regression. Additionally, we provide a straightforward formula for conservatively estimating the asymptotic variance, facilitating power calculations that reflect these efficiency gains. Our simulation study supports the theory. Even without an additive treatment effect, we observe increased power or reduced standard error. While population shifts from historical to trial data may dilute benefits, they do not introduce bias. We demonstrate reductions in the estimated variance through an analysis of clinical trial data provided by Novo Nordisk A/S.

Authors

Institutions

Publication Details

Journal
Statistics in Medicine
Published
2026-04-01
DOI
https://doi.org/10.1002/sim.70524
Citations
1
Primary Topic
Advanced Causal Inference Techniques
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment

Alejandro Schuler, Mark J. van der Laan, Emilie Højbjerre‐Frandsen
1 citations
Statistics in Medicine
Advanced Causal Inference Techniques
article

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment

Alejandro Schuler, Mark J. van der Laan, Emilie Højbjerre‐Frandsen
article en
1 citations

Abstract

In randomized clinical trials (RCTs), the accurate estimation of marginal treatment effects is crucial for determining the efficacy of interventions. Enhancing the statistical power of these analyses is a key objective for statisticians. The increasing availability of historical data from registries, prior trials, and health records presents an opportunity to improve trial efficiency. However, many methods for historical borrowing compromise strict type I error rate control. Building on the work by Schuler et al. on prognostic score adjustment for linear models, this paper extends the methodology to the plug-in analysis proposed by Rosenblum and van der Laan using generalized linear models (GLMs) to further enhance the efficiency of RCT analyses without introducing bias. Specifically, we train a prognostic model on historical control data and incorporate the resulting prognostic scores as covariates in the plug-in GLM analysis of the trial data. This approach leverages the predictive power of historical data to improve the precision of marginal treatment effect estimates. We demonstrate that this method achieves local semi-parametric efficiency under the assumption of an additive treatment effect on the link scale. We expand the GLM plug-in method to include Negative Binomial regression. Additionally, we provide a straightforward formula for conservatively estimating the asymptotic variance, facilitating power calculations that reflect these efficiency gains. Our simulation study supports the theory. Even without an additive treatment effect, we observe increased power or reduced standard error. While population shifts from historical to trial data may dilute benefits, they do not introduce bias. We demonstrate reductions in the estimated variance through an analysis of clinical trial data provided by Novo Nordisk A/S.

Statistics in MedicineVol. 45(8-9)
Novo Nordisk (Denmark) (DK), Aalborg University (DK), University of California, Berkeley (US)
Innovationsfonden
Openalex Percentile: Top 99%
Advanced Causal Inference Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.